广州医药 ›› 2016, Vol. 47 ›› Issue (5): 1-3.DOI: 10.3969/j.issn.1000-8535.2016.05.001

• 论著 •    下一篇

miR-221在前列腺癌细胞中的表达及对增殖的影响

毕学成1, 刘久敏1, 冯自卫1, 吴永定2   

  1. 1 广东省人民医院泌尿外科(广州 510080)
    2 广州医科大学公共卫生学院(广州 510180)
  • 收稿日期:2016-04-05 出版日期:2016-09-20 发布日期:2021-12-02
  • 通讯作者: 毕学成,E-mail:doctorbi1975@163.com
  • 基金资助:
    广东省医学科学技术研究基金项目(A2014016)

Effect of miR-221 expression on proliferation in prostate cancer cells

Bi Xuecheng, Liu Jiumin, Feng Ziwei, Wu Yongding   

  1. Bi Xuecheng, Liu Jiumin, Feng Ziwei. Department of Urology, Guangdong General Hospital, Guangzhou 510080, China
    Wu Yongding. School of Public Health, Guangzhou Medical University, Guangzhou 510180, China
  • Received:2016-04-05 Online:2016-09-20 Published:2021-12-02

摘要: 目的 研究前列腺癌细胞中miR-221的表达情况及其对癌细胞增殖的影响。方法 运用实时荧光定量PCR(qRT-PCR)检测miR-221在前列腺正常细胞株与前列腺癌细胞株中表达的差异情况,利用细胞转染构建miR-221过表达LNCaP和DU145细胞株,再通过CCK8细胞增殖实验检测细胞增殖情况的变化。结果 qRT-PCR检测细胞株发现miR-221在PC3、LNCaP和DU145三种前列腺癌细胞株中表达量均比前列腺正常细胞株PrEC低 (F=254.197,P<0.001),其中两两比较差异也均有统计学意义。细胞转染技术构建的miR-221过表达LNCaP和DU145细胞株,经qRT-PCR结果显示,miR-221在LNCaP和DU145细胞株中的表达水平明显升高(LNCaP,倍数变化=2.24,t=3.46,P<0.01;Du145,倍数变化=2.24,t=4.29,P<0.01)。细胞增殖实验结果显示,过表达了miR-221的LNCaP(P<0.001)和DU145(P<0.001)细胞生长速度慢于对照组。结论 实验证明miR-221表达过度能减慢前列腺癌细胞的增殖,miR-221有可能成为前列腺肿瘤治疗的生物学标志物。

关键词: 前列腺癌, miR-221, 细胞增殖

Abstract: Objective To investigate miR-221 expression in prostate cancer cells and its influence on prostate cancer cell proliferation. Methods miR-221 expressions in prostate normal cell lines and cancer cell lines were measured by qRT-PCR. Overexpression of the miR-221 in LNCaP and DU145 cell lines used by cell transfection. Effects of the depletion on cell proliferation were assessed in vitro with CCK8. Results qRT-PCR showed miR-221 was lower expressed in PC3, LNCaP and DU145 than in PrEC(F=254.197, P<0.001), in which pairwise comparison also had significant differences. qRT-PCR showed miR-221 expression rose significantly in LNCaP and DU145 cell lines whose miR-221 was overexpression with cell transfection(LNCaP, Fold Change=2.24,t=3.46,P<0.001;Du145, Fold Change=2.24,t=4.29,P<0.001). Cell proliferation assay showed that growth of LNCaP(P<0.001) and DU145(P<0.001) cells whose miR-221 was overexpression was slower than the control group. Conclusion This study demonstrates miR-221 overexpression can inhibited the proliferation of prostate cancer cells for the first time, it also suggests that miR-221 has the potential to serve as a biomarker for PCa therapy.

Key words: Prostate cancer, miR-221, Cell proliferation